| ||
| Roche's Avastin Shows Ovarian Cancer Benefit Wall Street Journal Avastin, which had $6.8 billion in 2010 sales, is already approved to treat lung, colon, kidney and brain cancers and Roche is hoping that use in ovarian cancer will help sustain its sales growth. It has already filed for approval in Europe and plans ... See all stories on this topic » | ||
| Cancer blood cell level linked to survival: study Focus News In another study released Saturday at the conference, a panel of lung cancer experts known as the "Lung Cancer Mutation Consortium" analyzed tumor samples from 830 patients and found that half of them had undergone at least one of 10 genetic mutations ... See all stories on this topic » | ||
| Therapy Matched to Tumor Abnormalities Tied to Longer Survival Internal Medicine News Digital Network Major Finding: Patients with advanced cancer who had therapy matched to molecular abnormalities in their tumors survived about 4 months longer than similar patients with unmatched therapy. Data Source: Molecular analyses of 1144 patients in a phase I ... See all stories on this topic » | ||
| ||
| Ovarian Cancer Screening Does Not Appear To Reduce Risk Of Ovarian Cancer Death Medical News Today (press release) Analysis of data indicated that the difference in survival between the intervention and usual care groups was not statistically significant. "All-cause mortality (excluding deaths from ovarian, colorectal, and lung cancer) was similar in the 2 study ... See all stories on this topic » | ||
| ASCO 2011: Erbitux Increased Overall Survival by 5.1 Months in Patients With ... National Post (registration) Merck is also investigating among other potential cancer treatments the use of Stimuvax ® (BLP25 Liposome Vaccine) in the treatment of non-small cell lung cancer. The vaccine was granted fast-track status in September 2004 by the FDA. ... See all stories on this topic » | ||
| ||
|
| ||
| Lung cancer patients' survival time could be doubl... - Silobreaker Lung cancer patients' survival time could be doubled with new drug. www.silobreaker.com/lung-cancer-patients-survival-time-coul... | ||
| Lung Cancer Survival Rate Information | Health Matters Now - Digg Lung cancer survival rate provides a statistics that indicate how lung cancer patients can survive the disease within a 5-year period after diagnosis. digg.com/.../lung_cancer_survival_rate_information_health_... | ||
| Drug 'doubles lung cancer survival' SCIENTISTS have discovered a pill that can double the survival chances of patients with lung cancer. upcoming.current.com/.../3777841_drug-doubles-lung-cancer... | ||
| Fuse.tv - A Drug Combination Extends Survival In Refractory Lung ... A Drug Combination Extends Survival In Refractory Lung Cancer Patients ... (14 hours ago); Drug 'doubles lung cancer survival' (23 hours ago) ... fuse.tv/news/articles/?article=05i50gs66A6p6 | ||
| Lung Cancer Symptoms Signs Survival Rates Prognosi - Health care ... Get the facts on lung cancer causes smoking types symptoms signs treatment prevention stages survival rates statistics prognosis and risk factors Get the ... www.r6k.net/.../lung-cancer-symptoms-signs-survival-rates-pr... |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment